|
|
Article: Research and Markets: Fragment-Based Drug Discovery: A Practical Approach is a Guide to the Techniques and Practice of Using Fragments in Drug Screening.
- Article from:
- Business Wire
- Article date:
- December 16, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/11d17a/fragmentbased_dru) has announced the addition of John Wiley and Sons Ltd's new report "Fragment-Based Drug Discovery: A Practical Approach" to their offering.
Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, cheaper, smarter way to do drug discovery, as shown by the number of pharmaceutical companies that have embraced this approach and the biotechnology companies who use fragments as their sole source of drug discovery.
Fragment-Based Drug Discovery: A ...